BioCentury
ARTICLE | Company News

Alba, University of Maryland deal

September 6, 2004 7:00 AM UTC

The university granted Alba exclusive rights to IP covering the zonulin pathway for all applications except diagnostics. The company said the zonulin pathway allows for the reversible opening and clos...